Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2010 / Cilt: 36 - Sayı: 4

Laparoscopic ureterolysis in surgery of idiopatic retroperitoneal fibrosis: our initial results

İdiyopatik retroperitoneal fibrozisin cerrahi tedavisinde laparoskopik üreterolizis: İlk sonuçlarımız

Pages
350–355
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

LU should be primary option in the surgical treatment of RF due to its minimal invasive nature and high efficacy.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: Retroperitoneal fibrozis (RF) is a disease characterized by inflammation and fibrosis in the retroperitoneum that generally causes ureteral obstruction.
📊
Key Findings & Data:Materials and methods: Between January 2007 and September 2009, 4 bilateral and 1 unilateral LU procedures (a total of 9 ureteral unit) were performed in 5 patients (4 males, 1 female) with a mean age of 57.2±6.1 years in our clinic.
💡
Conclusion & Impact:LU should be primary option in the surgical treatment of RF due to its minimal invasive nature and high efficacy.
🔬Design:Research Article
📍Scope:2007 Verileri
⚙️Variables:Domain Parameters

Abstract

Objective: Retroperitoneal fibrozis (RF) is a disease characterized by inflammation and fibrosis in the retroperitoneum that generally causes ureteral obstruction. In cases in which obstructive nephropaty is developed, this condition is treated by open, robotic or laparascopic ureterolysis (LU). In this study, we aimed to evaluate the outcomes of LU and ureteral intraperitonealization procedures which were performed for RF. Materials and methods: Between January 2007 and September 2009, 4 bilateral and 1 unilateral LU procedures (a total of 9 ureteral unit) were performed in 5 patients (4 males, 1 female) with a mean age of 57.2±6.1 years in our clinic. Clinical, perioperative and outcome data were prospectively collected and retrospectively analyzed. Results: Mean operation time was 141 min for unilateral pocedure while 277.5±27.5 (range 140-310) min for unilateral and bilateral procedures. Mean blood loss was 75 mL and 122.5±23.2 (range 100-145) mL for unilateral and bilateral cases, respectively. Mean drain withdrawal time was 2.2±0.8 (range 1-3) days and mean hospitalization time was 2.6±1.1 (range 1-4) days. Ureteral obstruction did not occur in any case during the 14.8±4.2 (range 8-19) months of follow-up. Conclusion: Our experiences show that LU can be peformed with low morbidity and high success rates. LU should be primary option in the surgical treatment of RF due to its minimal invasive nature and high efficacy.

Özet

Amaç: Retroperitonal fibrozis (RF) retroperitonda inflamasyon ve fibrozis ile seyreden ve sıklıkla üreteral obstrüksiyona neden olan bir hastalıktır. Obstrüktif nefropati gelişen olgularda tedavi olarak açık, robotik veya laparoskopik üreterolizis (LÜ) uygulanmaktadır. Bu çalışmada RF’li hastalara uyguladığımız LÜ ve üreteral intraperitonalizasyon sonuçlarını değerlendirmeyi amaçladık. Gereç ve yöntem: Kliniğimizde Ocak 2007 ile Eylül 2009 tarihleri arasında ortalama yaşı 57.2±6.1 olan 4’ü bilateral 1’i ünilateral olmak üzere toplam 5 hasta (4 erkek 1 kadın) ve 9 üreteral üniteye LÜ prosedürü uygulandı. Klinik, operasyona ait ve operasyon sonrası veriler ileriye yönelik olarak toplandı ve geriye yönelik olarak analiz edildi. Bulgular: Operasyon süresi ünilateral işlem için 141 dakika iken ortalama operasyon süresi bilateral işlemler için 277.5±27.5 (aralık: 250-310) dakika idi. Ortalama kan kaybı ünilateral ve bilateral işlemler için sırasıyla 75 mL ve 122.5±23.2 (dağılım 100-145) mL idi. Ortalama dren alınma süresi 2.2±0.8 (dağılım 1-3) gün ve ortalama hastanede kalış süresi 2.6±1.1 (dağılım 1-4) gündü. Ortalama 14.8±4.2 (dağılım 8-19) aylık takip süresince hiçbir hastada üreteral obstrüksiyon gelişmedi. Sonuç: Bulgularımız LÜ’nün düşük morbidite ve yüksek başarı oranları ile uygulanabildiğini göstermektedir. LÜ, RF tedavisinde, işlemin minimal invazif doğası ve yüksek etkinliği nedeniyle öncelikli tedavi seçeneği olmalıdır.

🔖

Cite This Article

BİNBAY, M., ASLAN, R., SARI, E., AKMAN, T., TEFEKLİ, A. H., MÜSLÜMANOĞLU, A. Y. (2010). Laparoscopic ureterolysis in surgery of idiopatic retroperitoneal fibrosis: our initial results. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 36 - Sayı: 4, 350–355. https://ajindex.com/articles/328996

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (3)

  1. Albarran J. Retention renale par peri ureterite: Liberation externe de l’uretere. Assoc Fr Urol 1905;9:511-7
  2. Ormond JK. Bilateral ureteral obstruction due to envelopment and compression by an inflammatory retroperitoneal process. J Urol 1948;59:1072-9. PMid:18858051 3. Kotra JJ, Dunnik NR. Retroperitonal fibrosis. Radiol Clin North Am 1996;34:1259-75. PMID: 8898793 4. Higgins PM, Bennet-Jones DN, Naish PF, Aber GM. Non-operative managment of retroperitoneal fibrosis. Br J Surg 1988:75:573-5. doi:10.1002/bjs.1800750625 PMid:3293696 5. Dehner LP, Coffin CM. Idiopathic fibrosclerotic disorders and other inflammatory pseudotumors. Semin Diagn Pathol 1998;15:161-4. PMid:9606807 6. Parums DV, Choudhory RP, Shields SA, Davies AH. Characterization of inflammatory cells associated with “idiopatic retroperitonal fibrosis” Br J Urol 1991;67:564-8. doi:10.1111/j.1464-410X.1991.tb15216.x PMid:2070198 7. Resnick MI, Kursh ED. Extrinsic obstruction of ureter. In: PC Walsh, AB Retik, TA Stamey and ED Waughan, editors. Campell’s Urology, 6th ed. Philadelphia: WB Saunders Co; 1992. p. 533
  3. Simone G, Leonardo C, Papalia R, Guaglianone S, Gallucci M. Laparoscopic ureterolysis and omental wrapping. Urology 2008;72:852-8. doi:10.1016/j.urology.2008.06.011 PMid:18674801 9. Alexopoulos E, Memmos D, Bakatselos S, Rombis V, Sakellariou G, Gaganakis J, et al. Idiopathic retroperitoneal fibrosis: a long-term follow-up study. Eur Urol 1987;13:313-7. PMid:3678303 10. Kardar LH, Kattan S, Lindstedt E, Hanash K. Steroid therapy for idiopathic retroperitoneal fibrosis: dose and duration. J Urol 2002;168:550-5. doi:10.1016/S0022-5347(05)64677-0 doi:10.1097/00005392-200208000-00031 PMid:12131307 11. Ilie CP, Pemperton RJ, Tolley DA. Idiopathic retroperitoneal fibrosis: the case for non-surgical treatment. Br J Urol 2006;98:137-40. PMID: 16831158 12. Moroni G, Gallelli B, Banfi G, Sandri S, Messa P, Ponticelli C. Long-term outcome of idiopathic retroperitoneal fibrosis treated with surgical and/or medical approaches. Nephrol Dial Transplant 2006;21:2485-90. doi:10.1093/ndt/gfl228 PMid:16702201 13. Koep L, Zuidema GD. The clinical significance of retroperitoneal fibrosis. Surgery 1977;81:250-5. PMid:841463 14. Miles RM, Brock J, Martin C. Idiopathic retroperitoneal fibrosis: a sometime surgical problem. Am Surg 1984;50:76-80. PMid:6703519 15. Elashry OM, Nakada SY, Wolf JS, Figenshau RS, McDougall EM, Clayman RV. Ureterolysis for extrinsic obstruction: a comparison of laparascopic a